Bottom Article Ad

Monday, November 8, 2021

Global Antisense and RNAi Therapeutics Market to be Driven by Companies that are developing Molecules based on Antisense Technology in the Forecast Period of 2021-2016

The new report by Expert Market Research titled, ‘Global Antisense and RNAi Therapeutics Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global antisense and RNAi therapeutics market, assessing the market based on its segments like end-product forms, equipment types, and applications. The report tracks the newest trends within the industry and studies their impact on the general market. It also assesses the market dynamics, covering the key demand and price indicators, alongside analysing the market supported the SWOT and Porter’s Five Forces models.



Note 1: For a snapshot of the primary and secondary data of the market (2016-2026), along with business strategies and detailed market segmentation, please click on request sample report. The sample report shall be delivered to you within 24 hours.


The key highlights of the report include:

Market Overview (2016-2026)

  • Forecast CAGR (2021-2026): 8.5%


Industry Definition and Major Segments

Specific and highly effective gene silencing is possible due to antisense and RNAi therapeutics. Antisense technology allows for the manipulation of gene expression, making it an effective therapy for ribonucleic acid targeting (RNA). Oncology, cardiovascular disease, respiratory disorders, renal disease, neurodegenerative disorders, genetic disorders, infectious diseases, and other conditions are all treated with it.

The Antisense and RNAi therapeutics industry can be divided based on:

  • Technology


    • RNA Interference
    • SiRNA
    • MiRNA
    • Antisense RNA

  • Route of Administration

    • Pulmonary Delivery
    • Intravenous Injections
    • Intra-dermal Injections
    • Intraperitoneal Injections
    • Topical Delivery

Market Trend

The global antisense and RNAi therapeutics industry is propelled by a deep understanding of gene function for disease management via the use of malfunctioning genes and the control of their gene expression. Various collaborations between pharmaceutical companies and contract research organisations working to improve drug delivery are also driving the market.

The global antisense and RNAi therapeutics market is being driven by the rising prevalence of infectious diseases and neurodegenerative disorders. Quality concealment techniques such as RNA impedance and antisense oligonucleotides are used to treat various neurodegenerative diseases by correcting freak qualities. To improve the in-vivo delivery of oligonucleotides, researchers are developing novel conveyance frameworks such as nanocarriers. Nanocarriers have been shown to improve bioavailability, transporting limits of siRNA payload, and providing high cooperation with target cells.

However, stringent regulations, a lengthy product approval process, high development costs, and a relatively small number of patients are just a few of the factors that contribute to the high cost of RNA interference drugs, which is expected to slow the market growth of antisense and RNAi therapeutics in the coming years.

Key Market Players

The major players within the market are OliX Pharmaceuticals Inc., Sanofi S.A, SAN (EPA), GlaxoSmithKline, GSK (LON), Ionis Pharmaceuticals, Benitec Biopharma Ltd, Silence Therapeutics Plc, Enzon Pharmaceuticals Inc, Antisense Therapeutics Ltd. and others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of those market players.

Read More Reports:-











Note 2: As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

We also provide state-of-the-art procurement intelligence through our platform, https://www.procurementresource.com. Procurement Resource is a leading platform for digital procurement solutions, offering daily price tracking, market intelligence, supply chain intelligence, procurement analytics, and category insights through our thoroughly researched and infallible market reports, production cost reports, price analysis, and benchmarking.

Informes de Expertos (https://www.informesdeexpertos.com), the Spanish variant of Expert Market Research, is a platform that offers market research and consultancy services to a broad clientele base across Spanish speaking countries. With our primary focus on the Latin America and Spain markets, our research experts provide relevant and actionable insights into the markets and track major trends, economic developments, and global trade data.

Determined to bring client satisfaction, we make sure that our tailored approach meets the client’s unique market intelligence requirements. Our syndicated and customized research reports cover a wide spectrum of industries ranging from pharmaceuticals and food and beverage to packaging, logistics, and transportation.

Media Contact

Company Name: EMR Inc.
Contact Person: Sofia Williams, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States
Website: https://www.expertmarketresearch.com


Introducing Procurement Resources Services of EMR Inc.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

0 Comments:

Post a Comment